J 2017

A head-to-head comparison of 4-L polyethylene glycol and low-volume solutions before colonoscopy: which is the best? A multicentre, randomized trial

KOJECKÝ, Vladimír; J. MATOUS; R. KEIL; Milan DASTYCH; Radek KROUPA et. al.

Základní údaje

Originální název

A head-to-head comparison of 4-L polyethylene glycol and low-volume solutions before colonoscopy: which is the best? A multicentre, randomized trial

Autoři

KOJECKÝ, Vladimír (203 Česká republika); J. MATOUS (203 Česká republika); R. KEIL (203 Česká republika); Milan DASTYCH (203 Česká republika, garant, domácí); Radek KROUPA (203 Česká republika, domácí); Z. ZADOROVA (203 Česká republika); M. VARGA (203 Česká republika); Jiří DOLINA (203 Česká republika, domácí); M. KMENT (203 Česká republika) a Aleš HEP (203 Česká republika, domácí)

Vydání

International Journal of Colorectal Disease, New York, Springer, 2017, 0179-1958

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30219 Gastroenterology and hepatology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 2.533

Kód RIV

RIV/00216224:14110/17:00098392

Organizační jednotka

Lékařská fakulta

UT WoS

000415692100014

EID Scopus

2-s2.0-85029905735

Klíčová slova anglicky

Ascorbic acid; Colonoscopy; Magnesium citrate; Picosulfate sodium; Polyethylene glycol

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 15. 3. 2018 17:06, Soňa Böhmová

Anotace

V originále

Purpose: The purpose of this study is to compare the efficacy and tolerability of polyethylene glycol (PEG) to sodium picosulfate/magnesium citrate (SPMC) and low-volume polyethylene glycol/ascorbic acid (PEGA) in a single- or split-dose regimen for colonoscopy bowel preparation. Methods: This was a prospective, randomized, endoscopist-blinded, multicentre study. Outpatients received either PEG or SPMC or PEGA in a single or a split dose before the colonoscopy. Quality and tolerability of the preparation and complaints during preparation were recorded. Results: Nine hundred seventy-three patients were analysed. Satisfactory bowel cleansing (Aronchick score 1 + 2) was more frequent when a split dose was used irrespective of the solution type (PEG 90.1 vs 68.8%, PEGA 86.0 vs 71.6%, SPMC 84.3 vs 60.2%, p < 0.001). SPMC was the best tolerated followed by PEGA (p < 0.006) and PEG as the worst (p < 0.001). Tolerability did not correlate with the regimen and amount of the solution used. Female gender is associated with a higher incidence of nausea, vomiting and pain (p < 0.029). Conclusions: Both PEG, PEGA and SPMC are fully comparable in terms of colonic cleansing when used in similar regimens. The split-dose preparation is more effective in all agents. SPMC and PEGA are better tolerated than PEG. The preparation regimen and/or the volume do not affect tolerability.